Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
74 Leser
Artikel bewerten:
(0)

Standard & Poor's Announces an Update to the U.S. Indices Liquidity Criteria and a Change to U.S. Index

NEW YORK, Aug. 18 /PRNewswire/ -- Standard & Poor's is updating the liquidity eligibility criteria for additions to its U.S. indices. Effective today, additions to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices should have a float adjusted liquidity ratio of 1.00 or greater. Float adjusted liquidity is measured as the ratio of annual dollar value traded to float adjusted market capitalization. In addition, the company should have a minimum monthly trading volume of 250,000 shares in each of the six months leading up to the evaluation date. For inclusion in the S&P Total Market Index, additions should have a float adjusted liquidity ratio of 0.10.

Sigma Designs Inc. will replace Noven Pharmaceuticals Inc. in the S&P SmallCap 600 after the close of trading on a date to be announced. Hisamitsu Pharmaceutical Co. is acquiring Noven in a deal expected to be completed soon.

Standard & Poor's will monitor this transaction, and post any relevant updates on its website: http://www.standardandpoors.com/.

Sigma Designs develops and markets high-performance, highly-integrated System-on-a-Chip semiconductors. Headquartered in Milpitas, CA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Semiconductors Sub-Industry index.

Following is a summary of the change: S&P SMALLCAP 600 INDEX - TBA COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY ADDED Sigma Designs Information Technology Semiconductors DELETED Noven Pharmaceuticals Health Care Pharmaceuticals About Standard & Poor's Index Services

Standard & Poor's Index Services, the world's leading index provider, maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Over $1 trillion is directly indexed to Standard & Poor's family of indices, which includes the S&P 500, the world's most followed stock market index, the S&P Global 1200, a composite index comprised of seven regional and country headline indices, the S&P Global BMI, an index with approximately 11,000 constituents, and the S&P GSCI, the industry's most closely watched commodities index. For more information, please visit http://www.standardandpoors.com/indices.

About Standard & Poor's

Standard & Poor's, a subsidiary of The McGraw-Hill Companies , is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research and data. With offices in 23 countries and markets, Standard & Poor's is an essential part of the world's financial infrastructure and has played a leading role for nearly 150 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit http://www.standardandpoors.com/.

Standard & Poor's

CONTACT: David M. Blitzer, Ph.D., Managing Director & Chairman of the
Index Committee, +1-212-438-3907

Web Site: http://www.standardandpoors.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.